| Literature DB >> 31620019 |
Kaitlin N Allen1, José Pablo Vázquez-Medina1.
Abstract
Reperfusion injury follows ischemia/reperfusion events occurring during myocardial infarction, stroke, embolism, and other peripheral vascular diseases. Decreased blood flow and reduced oxygen tension during ischemic episodes activate cellular pathways that upregulate pro-inflammatory signaling and promote oxidant generation. Reperfusion after ischemia recruits inflammatory cells to the vascular wall, further exacerbating oxidant production and ultimately resulting in cell death, tissue injury, and organ dysfunction. Diving mammals tolerate repetitive episodes of peripheral ischemia/reperfusion as part of the cardiovascular adjustments supporting long duration dives. These adjustments allow marine mammals to optimize the use of their body oxygen stores while diving but can result in selectively reduced perfusion to peripheral tissues. Remarkably, diving mammals show no apparent detrimental effects associated with these ischemia/reperfusion events. Here, we review the current knowledge regarding the strategies marine mammals use to suppress inflammation and cope with oxidant generation potentially derived from diving-induced ischemia/reperfusion.Entities:
Keywords: cetacean; hypoxia; inflammation; oxidative stress; pinniped
Year: 2019 PMID: 31620019 PMCID: PMC6763568 DOI: 10.3389/fphys.2019.01199
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Biochemical mechanisms leading to the prevention of reperfusion injury in diving mammals. Ischemia/reperfusion events are associated with oxidative stress and inflammation in humans but are well tolerated by diving mammals. The mechanisms marine mammals use to prevent inflammation and oxidative stress derived from diving-induced ischemia and hypoxemia are still under investigation but likely include upregulation of genes involved in antioxidant defense and hypoxia tolerance via preconditioning-like responses that involve activation of the transcription factors Nrf2 and HIF-1.